Core Laboratories NV (CLB) financials · P/E 21, rev $526.5M
Core Laboratories NV (CLB) P/E 21, rev $526.5M.
| Line | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | $526.5M | $523.8M | $509.8M |
| Cost of Revenue | $417.6M | $420.5M | $400.0M |
| Gross Profit | $108.9M | $103.3M | $109.8M |
| Operating Income | $56.5M | $58.6M | $54.6M |
| Net Income | $29.7M | $31.4M | $36.7M |
| EPS (Diluted) | $0.63 | $0.66 | $0.77 |
| Line | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Total Assets | $584.0M | $590.4M | $586.4M |
| Current Assets | $214.7M | $226.6M | $223.1M |
| Cash & Equivalents | $22.7M | $19.2M | $15.1M |
| Inventory | $54.5M | $59.4M | $71.7M |
| PP&E | $99.4M | $97.1M | $99.6M |
| Total Liabilities | $584.0M | $590.4M | $586.4M |
| Current Liabilities | $106.0M | $97.6M | $88.1M |
| Short-term Debt | $0 | $0 | $0 |
| Long-term Debt | $110.3M | $126.1M | $163.1M |
| Total Debt | $110.3M | $126.1M | $163.1M |
| Shareholders' Equity | $266.0M | $252.0M | $224.8M |
| Retained Earnings | $172.7M | $150.3M | $120.8M |
| Line | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Operating Cash Flow | $37.0M | $56.4M | $24.8M |
| CapEx | $11.2M | $13.0M | $10.6M |
| Investing Cash Flow | -$2.2M | -$6.4M | -$6.7M |
| Financing Cash Flow | -$31.3M | -$46.0M | -$18.4M |
| Dividends Paid | $1.9M | $1.9M | $1.9M |
| Net Change in Cash | $0 | $0 | $0 |
| Free Cash Flow | $25.8M | $43.4M | $14.2M |
FAQ
What is CLB P/E and revenue?
Core Laboratories NV (CLB) P/E 21, rev $526.5M.
What is CLB revenue?
Core Laboratories NV last cached revenue is $526.5M (FY2025).
Is CLB profitable?
Core Laboratories NV last cached net income is $29.7M.
What are CLB total assets?
Core Laboratories NV last cached total assets are $584.0M.
What is CLB free cash flow?
Core Laboratories NV last cached free cash flow is $25.8M.
Not investment advice. Cached statements, not a live tape.